Bristol-Myers Squibb Co (BUE:BMY) FFO

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

BUE:BMY Bristol-Myers Squibb Co BUE:BMY
56 GF Score
Price ARS30,980.00
GF Value ARS28,025.90
Valuation Modestly Overvalued
! 6 Warning Signs
View Full Analysis

What is Bristol-Myers Squibb Co FFO?

FFO (Funds from operations) only applies to REITs.

BUE:BMY
56GF Score
Bristol-Myers Squibb Co BUE:BMY
FFO is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Is Bristol-Myers Squibb Co (BUE:BMY) Overvalued in 2026?

Based on GuruFocus' analysis, Bristol-Myers Squibb Co stock appears to be overvalued. The current stock price of ARS30,980.00 is trading 10.5% above its estimated GF Value™ of ARS28,025.90. GuruFocus considers Bristol-Myers Squibb Co to be Modestly Overvalued.

Key valuation signals for BUE:BMY:

  • FFO:
  • GF Value™: ARS28,025.90 vs. price of ARS30,980.00 (10.5% above fair value)
  • GF Score™: 56/100 with 6 warning signs

No single metric tells the full story. See the BUE:BMY stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Bristol-Myers Squibb Co Business Description

Address Route 206 and Province Line Road, Princeton, New Jersey, NJ, USA, 08543
Bristol Myers Squibb discovers, develops, and markets drugs for various therapeutic areas, such as cardiovascular, cancer, and immune disorders. A key focus for Bristol is immuno-oncology, where the firm is a leader in drug development. Bristol derives close to 70% of total sales from the US, showing a higher dependence on the US market than most of its peer group.
56GF Score

Get the complete analysis for BUE:BMY

FFO is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

ARS30,980.00
Price
ARS28,025.90
GF Value